#68. Molecular Glues in Therapy

In this episode, we explore the rapid evolution of molecular glues, a breakthrough in targeted protein degradation that stabilizes protein interactions to treat previously incurable diseases. Historically discovered by chance, this field is moving toward a systematic design approach by integrating artificial intelligence, functional genomics, and biased chemical libraries. Current research emphasizes using machine learning to predict complex protein interfaces and utilizing covalent bonding to improve drug potency. Furthermore, a strategic partnership between Protina and Onconic Therapeutics highlights the commercial push to apply these AI-driven platforms to develop next-generation cancer therapies. Collectively, the texts illustrate how the fusion of computational modeling and synthetic biology is transforming "serendipitous" discoveries into a programmable era of pharmacology. Produced by Dr. Jake Chen.